RedditBluesky
  • Home
  • Artificial Intelligence
  • Cryptocurrencies
  • Technology
  • Gold
  • Stocks
Home » News » Why the legal cannabis industry is popular in the American South

Why the legal cannabis industry is popular in the American South

Some of the largest THC companies are south of the Mason-Dixon line

Justin Wong (JW)October 5, 2026



When it comes to cannabis, states like California, Colorado, and Oregon get the most attention. But some of the nation's largest marijuana companies have their roots south of the Mason-Dixon Line.

"The south is the biggest frontier for cannabis," said Jim Cacioppo, the CEO of Jushi, a marijuana company that operates 26 pharmacies in Virginia, Pennsylvania, California, Illinois and Massachusetts. "It's only a matter of time."

Jushi has two pharmacies in Virginia but plans to open a total of six by 2023. His company's stores are located outside of Washington, D.C., in Alexandria, Arlington, and Fairfax. Cacioppo says that while California holds the title of the nation's largest marijuana market in terms of annual sales, he sees states like Virginia and Georgia as having the greatest potential for growth.

"We consider Virginia one of the best licenses for cannabis," said Cacioppo, explaining that his company has the exclusive right to weed in the suburbs of D.C. with its 2.5 million inhabitants legally for sale. "That is the cornerstone of Jushi."

Virginia is still a small medical market. But with a population of over 8.5 million, it has the potential to grow larger than Colorado, which has 5.7 million residents and a cannabis market of $ 2.1 billion (annual sales).

Virginia started medicinal sales in late 2020. Cacioppo says the upward trend hasn't even started - Virginia is expected to start its adult use program in 2024.

"It has tremendous momentum," he says. "If you introduce adult use, sales could triple overnight.

It's no secret: most Americans believe that cannabis should be legal. And legalization continues to spread from state to state, with 36 states already regulating their own cannabis markets. According to the latest Gallup poll, 68% of Americans are in favor of legalization, with 83% of Democrats, 71% of Independents, and 50% of Republicans in favor of lifting prohibition.

For decades, the Democrats have spearheaded the issue of cannabis legalization. But that is no longer the case. On Election Day in November 2020, a wave of states usually considered Republican passed legal cannabis laws. Arizona, Mississippi, Montana and South Dakota have all voted to legalize either medical marijuana or adult cannabis, which has revealed what was previously hidden: cannabis is neither a red nor a blue issue.

This week, South Carolina Republican Nancy Mace tabled a bill that would end federal cannabis prohibition. The bill includes some classic Republican positions, a low federal excise tax, and the right of states to legislate the drug of their own, but it is further evidence that marijuana legalization has support on both sides of the aisle. Perhaps one of the biggest signals that legalization is no longer a neo-hippie thing is the fact that Charles Kochs Americans for Prosperity supports the Mace bill.

"For a long time there was a perception that cannabis was a partisan issue," said Kim Rivers, CEO of Florida-based cannabis company Trulieve. "This image has changed and evolved over time. It seems to be more of a topic in its own right for people, not necessarily related to their other political or ideological views."

The lion's share of Trulieve's business is based on the theory that cannabis is impartial. The company is the largest player in the $ 1 billion medical marijuana market in Florida, has acquired Arizona-based Harvest, has a strong presence in Pennsylvania, has expanded into West Virginia, and is licensed in Georgia.

On Friday, November 12th, about 100 people lined up outside West Virginia's first marijuana dispensary to wait for it to open at 10 a.m. Trulieve opened the state's first marijuana dispensary in Morgantown, home of West Virginia University. Days later and 59 miles further south, Trulieve opened another pharmacy in Weston.

"We think this is going to be a really strong market and we've invested in the entire supply chain," says Rivers.

Rivers says the company has nine retail location licenses in West Virginia and will open all nine within the next 12 months.

Trulieve is on the rise in Georgia too. Georgia legalized low-THC oil and products for medical use in 2015, but the state's sluggish process - marked by slow-moving bureaucracy and protests - has delayed the start of the state program. Six companies, including Trulieve, were awarded the licenses, but the start of the program has been postponed indefinitely as regulators are now on a process to hear complaints from 15 companies that have won the weed sale Had lost peach state. Legislators will meet before the end of the year to consider revising the program and starting over.

For Trulieve, the expansion to Georgia also makes logistical sense.

"Georgia is of course our neighbor to the north," says Rivers. "There are a lot of connections there. We currently have around 200 employees living in Georgia.

Rivers says it will be able to share resources, people and supplies across state lines. While cannabis cannot cross state lines because it is still illegal at the federal level, international trade will likely one day be legal.

"At some point we will also have the advantage that the actual [cannabis] product can be moved across national borders," says Rivers.

Zane Bader, founder of the Georgia Cannabis Trade Association, believes the state could be a multibillion dollar market in 10 to 20 years.

"We have a population of 10 million people and Atlanta could be a distribution center," says Bader. "Long-term, I'd say the revenue potential is comparable to Illinois.

In May, Green Thumb Industries announced a $ 83 million acquisition of medical cannabis operator Dharma in Virginia. Virginia has a limited program that licenses only five companies to grow and sell marijuana.

With a population of 8.5 million in the state, GTI is one of five companies serving the new legal cannabis market, according to Kovler, in the right place at the right time, especially if the state introduces adult marijuana sales in 2024.

Kovler is optimistic about Old Dominion. "We love the Virginia market," he told Forbes at the time of the Dharma acquisition. "It is the beginning of what is happening in the south, which is currently a [legal] cannabis desert."

Cannabis





Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.


Claw and Order: Antimony Rules the Resource Realm
Read Next

Claw and Order: Antimony Rules the Resource Realm

  • RIDE THE BULL

    Your Front Row Seat to the Stories That Move Markets. – Subscribe Now to our Newsletter!

  • Trending Now

    • Mark Carney Single-Outs NexGen's Rook 1 as a Critical Project of National Interest
      Mark Carney Single-Outs NexGen's Rook 1 as a Critical Project of National Interest
    • Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
      Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
    • Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
      Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
    • Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama
      Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama

Claim Your Spot with Juniorstocks.com

Unlock the stories that move markets directly in your inbox


ContactDisclaimerData PrivacyTerms of Use
  • Bluesky
  • Reddit
Copyright 2026 ©Juniorstocks.com - All Rights Reserved.